People David Burger Pharmacology of antiviral drugs (HIV and HCV)

Pharmacology of antiviral drugs

This group investigates the pharmacology of antiviral drugs for the treatment of HIV and hepatitis C in special patient population such as pregnant women, children and hepatically impaired patients. We also study drug-drug interactions and the impact on exposure of new formulations of the drugs.

Research group leader

David Burger PhD
full professor

+31 (0)24 361 64 05


  • To improve the healthcare of special patient populations living with HIV and/or hepatitis C
  • To set up and maintain international networks to perform these complex studies
  • To contribute to treatment guidelines of special patient populations

Setting up a European network PANNA

Our research group has set up a European network of centers that are willing and able to collect pharmacokinetic data in pregnant HIV-infected women using newly developed antiretroviral agents. go to website


Radboud Institute for Health Sciences

Ideally, every procedure in clinical practice and public health should take place based on proof, instead of intuition or 'experience'. Our aim is to innovate and personalize healthcare and public health. read more